메뉴 건너뛰기




Volumn 17, Issue 1, 2015, Pages 184-193

Biodegradable Microparticles Loaded with Doxorubicin and CpG ODN for In Situ Immunization Against Cancer

Author keywords

cancer vaccine; CpG; doxorubicin; in situ immunization; microparticles; PLGA

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; DOXORUBICIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CTLA4; MONOCLONAL ANTIBODY OX40; POLYGLACTIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CPG-OLIGONUCLEOTIDE; DELAYED RELEASE FORMULATION; IMMUNOLOGICAL ADJUVANT; LACTIC ACID; MICROSPHERE; OLIGODEOXYRIBONUCLEOTIDE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

EID: 84922101073     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-014-9676-6     Document Type: Article
Times cited : (57)

References (20)
  • 3
    • 84255197842 scopus 로고    scopus 로고
    • Cancer immunotherapy comes of age
    • COI: 1:CAS:528:DC%2BC3MXhs1GksLjO, PID: 22193102
    • Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480(7378):480–9.
    • (2011) Nature , vol.480 , Issue.7378 , pp. 480-489
    • Mellman, I.1    Coukos, G.2    Dranoff, G.3
  • 6
    • 0030713362 scopus 로고    scopus 로고
    • Anthracyclines in the treatment of cancer. An overview
    • COI: 1:CAS:528:DyaK2sXntlygu7w%3D, PID: 9361955
    • Hortobagyi GN. Anthracyclines in the treatment of cancer. An overview. Drugs. 1997;54 Suppl 4:1–7.
    • (1997) Drugs , vol.54 , pp. 1-7
    • Hortobagyi, G.N.1
  • 8
    • 0036476320 scopus 로고    scopus 로고
    • From A to Z on CpG
    • COI: 1:CAS:528:DC%2BD38XivVSmu7s%3D, PID: 11929127
    • Krieg AM. From A to Z on CpG. Trends Immunol. 2002;23(2):64–5.
    • (2002) Trends Immunol , vol.23 , Issue.2 , pp. 64-65
    • Krieg, A.M.1
  • 10
    • 84861630513 scopus 로고    scopus 로고
    • An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy
    • COI: 1:CAS:528:DC%2BC38Xot12qsb4%3D, PID: 22666458
    • Zhang H, Liu L, Yu D, Kandimalla ER, Sun HB, Agrawal S, et al. An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy. PLoS One. 2012;7(5):e38111.
    • (2012) PLoS One , vol.7 , Issue.5 , pp. e38111
    • Zhang, H.1    Liu, L.2    Yu, D.3    Kandimalla, E.R.4    Sun, H.B.5    Agrawal, S.6
  • 12
    • 72149113039 scopus 로고    scopus 로고
    • Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice
    • COI: 1:CAS:528:DC%2BD1MXhs1Slu7jL
    • Mizuno Y, Naoi T, Nishikawa M, Rattanakiat S, Hamaguchi N, Hashida M, et al. Simultaneous delivery of doxorubicin and immunostimulatory CpG motif to tumors using a plasmid DNA/doxorubicin complex in mice. J Control Release Off J Control Release Soc. 2010;141(2):252–9.
    • (2010) J Control Release Off J Control Release Soc , vol.141 , Issue.2 , pp. 252-259
    • Mizuno, Y.1    Naoi, T.2    Nishikawa, M.3    Rattanakiat, S.4    Hamaguchi, N.5    Hashida, M.6
  • 15
    • 4544387614 scopus 로고    scopus 로고
    • Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells
    • PID: 15368253
    • Yoshida M, Babensee JE. Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells. J Biomed Mater Res A. 2004;71(1):45–54.
    • (2004) J Biomed Mater Res A , vol.71 , Issue.1 , pp. 45-54
    • Yoshida, M.1    Babensee, J.E.2
  • 16
    • 58849160540 scopus 로고    scopus 로고
    • Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
    • COI: 1:CAS:528:DC%2BD1MXht12itr4%3D, PID: 19139407
    • Sharp FA, Ruane D, Claass B, Creagh E, Harris J, Malyala P, et al. Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A. 2009;106(3):870–5.
    • (2009) Proc Natl Acad Sci U S A , vol.106 , Issue.3 , pp. 870-875
    • Sharp, F.A.1    Ruane, D.2    Claass, B.3    Creagh, E.4    Harris, J.5    Malyala, P.6
  • 17
    • 65349153756 scopus 로고    scopus 로고
    • T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
    • COI: 1:CAS:528:DC%2BD1MXkslCku7c%3D, PID: 18941113
    • Houot R, Levy R. T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy. Blood. 2009;113(15):3546–52.
    • (2009) Blood , vol.113 , Issue.15 , pp. 3546-3552
    • Houot, R.1    Levy, R.2
  • 19
    • 77958018335 scopus 로고    scopus 로고
    • Immune regulatory antibodies: are they the next advance?
    • COI: 1:CAS:528:DC%2BC3cXhtFGnurvJ, PID: 20693841
    • Wolchok JD, Yang AS, Weber JS. Immune regulatory antibodies: are they the next advance? Cancer J. 2010;16(4):311–7.
    • (2010) Cancer J , vol.16 , Issue.4 , pp. 311-317
    • Wolchok, J.D.1    Yang, A.S.2    Weber, J.S.3
  • 20
    • 11144310004 scopus 로고    scopus 로고
    • Intratumoral immunotherapy: using the tumour against itself
    • COI: 1:CAS:528:DC%2BD2MXlt1KrsA%3D%3D, PID: 15606790
    • Crittenden MR, Thanarajasingam U, Vile RG, Gough MJ. Intratumoral immunotherapy: using the tumour against itself. Immunology. 2005;114(1):11–22.
    • (2005) Immunology , vol.114 , Issue.1 , pp. 11-22
    • Crittenden, M.R.1    Thanarajasingam, U.2    Vile, R.G.3    Gough, M.J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.